We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fluorescent Markers May Aid Cancer Diagnostics by Tracking Metabolites

By LabMedica International staff writers
Posted on 15 Apr 2019
Print article
Image: New imaging technology based on fluorescent chemical probes enables visualization of what cells eat, which could aid the diagnosis and treatment of diseases such as cancer (Photo courtesy of the University of Edinburgh).
Image: New imaging technology based on fluorescent chemical probes enables visualization of what cells eat, which could aid the diagnosis and treatment of diseases such as cancer (Photo courtesy of the University of Edinburgh).
A novel class of fluorescent markers allows real‐time tracking of essential metabolites in live cells in culture and in vivo in order to trace the acquisition of metabolic profiles from human cancer cells of variable origin.

The transport and trafficking of metabolites are critical for the correct functioning of live cells. However, in situ metabolic imaging studies are hampered by the lack of fluorescent chemical structures that allow direct monitoring of small metabolites under physiological conditions with high spatial and temporal resolution.

To improve this situation, investigators at the University of Edinburgh (United Kingdom) developed a novel class of small‐sized multi‐colored fluorophores for real‐time tracking of essential metabolites in live cells. These "SCOTfluors" (small, conjugatable, orthogonal, and tunable fluorophores) permitted visualization by microscope of minute changes in cells' incorporation of metabolites within the body's tissues, making it easier to identify sites of disease.

Senior author Dr. Marc Vendrell, senior lecturer in biomedical imaging at the University of Edinburgh, said, "We have very few methods to measure what cells eat to produce energy, which is what we know as cell metabolism. Our technology allows us to detect multiple metabolites simultaneously and in live cells, by simply using microscopes. This is a very important advance to understand the metabolism of diseased cells and we hope it will help develop better therapies."

The SCOTfluors paper was published in the March 28, 2019, online edition of the journal Angewandte Chemie.

Related Links:
University of Edinburgh

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more